Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,492 papers from all fields of science
Search
Sign In
Create Free Account
BRCA2 gene
Known as:
BRCC2
, BRCA2 Genes
, BRCA2
Expand
A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
29 relations
BLID gene
BRCA2 Ag:PrThr:Pt:Tiss:Ord:Immune stain
BRCA2 Gene Mutation
BRCA2 Protein
Expand
Narrower (1)
BRCA2 wt Allele
Broader (1)
brca gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Presenilin 1 Regulates Epidermal Growth Factor Receptor Turnover and Signaling in the Endosomal-Lysosomal Pathway*
Emanuela Repetto
,
I. Yoon
,
Hui Zheng
,
D. Kang
Journal of Biological Chemistry
2007
Corpus ID: 45919130
Mutations in the gene encoding presenilin 1 (PS1) cause the most aggressive form of early-onset familial Alzheimer disease. In…
Expand
Review
2004
Review
2004
From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold.
A. Bochkarev
,
E. Bochkareva
Current Opinion in Structural Biology
2004
Corpus ID: 14827667
Highly Cited
2003
Highly Cited
2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
R. Oldenburg
,
K. Kroeze-Jansema
,
+11 authors
P. Devilee
Cancer Research
2003
Corpus ID: 2988642
The frame-shifting mutation 1100delC in the cell-cycle-checkpoint kinase 2 gene (CHEK2) has been reported to be associated with…
Expand
Highly Cited
2002
Highly Cited
2002
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
N. Kauff
,
J. Satagopan
,
+9 authors
K. Offit
2002
Corpus ID: 75208468
In the 6 years from mid-1995 to mid-2001, 177 women from the Genetics Service at Memorial Sloan-Kettering who were found to carry…
Expand
Highly Cited
2002
Highly Cited
2002
Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation.
K. Trenz
,
A. Rothfuss
,
P. Schütz
,
G. Speit
Mutation research
2002
Corpus ID: 24559218
Highly Cited
2001
Highly Cited
2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
L. Verhoog
,
A. M. W. Ouweland
,
+11 authors
H. Meijers-Heijboer
European Journal of Cancer
2001
Corpus ID: 23733812
Highly Cited
2000
Highly Cited
2000
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary
M. van der Looij
,
C. Szabo
,
+7 authors
E. Oláh
International Journal of Cancer
2000
Corpus ID: 25394976
We have investigated the impact of BRCA1 and BRCA2 mutations that were frequently identified among Hungarian high‐risk breast…
Expand
Highly Cited
2000
Highly Cited
2000
The CAG repeat within the androgen receptor gene in male breast cancer patients
M. Bahuau
,
I. Laurendeau
,
+10 authors
Dominique Vidaud
Journal of Medical Genetics
2000
Corpus ID: 30822796
Editor—In the December 1998 issue of Journal of Medical Genetics , four letters discussed whether or not Kenny-Caffey syndrome…
Expand
Highly Cited
1999
Highly Cited
1999
Clinicopathologic analysis of BRCA1‐ or BRCA2‐associated hereditary breast carcinoma in Japanese women
S. Noguchi
,
T. Kasugai
,
Y. Miki
,
T. Fukutomi
,
M. Emi
,
T. Nomizu
Cancer
1999
Corpus ID: 41590332
The purpose of this investigation was to elucidate the clinicopathologic characteristics of BRCA1‐ and BRCA2‐associated…
Expand
Highly Cited
1996
Highly Cited
1996
Cell cycle control of BRCA2.
J. Vaughn
,
F. D. Cirisano
,
+4 authors
J. Iglehart
Cancer Research
1996
Corpus ID: 15928317
Identifying the conditions and kinetics of the induction of BRCA2 gene expression may implicate roles for the function of the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE